Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Net Income (Quarterly) : -178.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -178.92M |
| March 31, 2026 | -137.57M |
| December 31, 2025 | 28.24M |
| September 30, 2025 | 16.12M |
| June 30, 2025 | -178.65M |
| March 31, 2025 | 367.86M |
| December 31, 2024 | -175.22M |
| September 30, 2024 | -173.34M |
| June 30, 2024 | -173.98M |
| March 31, 2024 | -127.00M |
| December 31, 2023 | -135.38M |
| September 30, 2023 | -111.02M |
| June 30, 2023 | -104.12M |
| March 31, 2023 | 47.68M |
| December 31, 2022 | -41.81M |
| September 30, 2022 | -85.94M |
| June 30, 2022 | -72.05M |
| March 31, 2022 | 44.37M |
| December 31, 2021 | -62.87M |
| September 30, 2021 | -63.37M |
| June 30, 2021 | -29.92M |
| March 31, 2021 | -26.82M |
| December 31, 2020 | -20.73M |
| September 30, 2020 | -48.43M |
| June 30, 2020 | -13.61M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.84M |
| December 31, 2019 | -2.674M |
| September 30, 2019 | 11.70M |
| June 30, 2019 | 20.34M |
| March 31, 2019 | 23.90M |
| December 31, 2018 | 12.04M |
| September 30, 2018 | -10.76M |
| June 30, 2018 | -15.61M |
| March 31, 2018 | -14.88M |
| December 31, 2017 | -13.20M |
| September 30, 2017 | -10.73M |
| June 30, 2017 | -5.520M |
| March 31, 2017 | -6.043M |
| December 31, 2016 | -12.09M |
| September 30, 2016 | -22.22M |
| June 30, 2016 | -19.42M |
| March 31, 2016 | -20.82M |
| December 31, 2015 | -19.26M |
| September 30, 2015 | -24.74M |
| June 30, 2015 | -15.94M |
| March 31, 2015 | -28.68M |
| December 31, 2014 | -22.58M |
| September 30, 2014 | -22.43M |
| June 30, 2014 | -11.63M |
| March 31, 2014 | -13.98M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -4.89M |
| Moderna, Inc. | -782.00M |
| Revolution Medicines, Inc. | -644.37M |
| Intellia Therapeutics, Inc. | -106.63M |
| Denali Therapeutics, Inc. | -127.55M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 75.25M |
| Total Expenses (Quarterly) | 269.53M |
| EPS Diluted (Quarterly) | -1.355 |
| Enterprise Value | 8.834B |
| Gross Profit Margin (Quarterly) | 91.15% |
| Profit Margin (Quarterly) | -237.8% |
| Earnings Yield | -3.49% |
| Normalized Earnings Yield | -3.494 |